Agarwal, Anish K.
Gonzales, Rachel E.
Southwick, Lauren
Schroeder, Devon
Sharma, Meghana
Bellini, Lisa
Asch, David A.
Mitra, Nandita
Balachandran, Mohan
Wolk, Courtney Benjamin
Becker-Haimes, Emily M.
Kishton, Rachel E.
Beck, Sarah
Merchant, Raina M.
Funding for this research was provided by:
National Institute of Mental Health (1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01, 1R01MH127686-01)
Article History
Received: 1 November 2024
Accepted: 31 March 2025
First Online: 7 May 2025
Declarations
:
: Approved by the University of Pennsylvania Institutional Review Board (#848844).
: Not applicable.
: Dr Merchant is the PI of NIH NHLBI R01HL1-141844, NIH/DHHS R01 MH127686, and NIH K24 HL157621. David A. Asch, MD, MBA is partner and part owner of VAL Health and serves as an advisor to Thrive Global. The research team was supported by the NIMH R01 MH127686.